​

Insmed (INSM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INSM Stock Forecast

Insmed (INSM) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $226.67, with a high of $269.00 and a low of $180.00. This represents a 16.12% increase from the last price of $195.20.

- $60 $120 $180 $240 $300 High: $269 Avg: $226.67 Low: $180 Last Closed Price: $195.2

INSM Stock Rating

Insmed stock's rating consensus is Buy, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 31 Buy (91.18%), 2 Hold (5.88%), 1 Sell (2.94%), and 0 Strong Sell (0.00%).

Buy
Total 34 1 2 31 Strong Sell Sell Hold Buy Strong Buy

INSM Price Target Upside V Benchmarks

TypeNameUpside
StockInsmed16.12%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts31113
Avg Price Target$262.67$220.91$206.15
Last Closing Price$195.20$195.20$195.20
Upside/Downside34.56%13.17%5.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 251161--18
Nov, 253151--19
Oct, 253141--18
Sep, 252151--18
Aug, 25414---18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 10, 2025Jefferies$269.00$194.5238.29%37.81%
Dec 04, 2025Redburn Partners$263.00$206.7827.19%34.73%
Dec 01, 2025Graig SuvannavejhMizuho Securities$256.00$207.7723.21%31.15%
Oct 31, 2025Goldman Sachs$225.00$190.3018.23%15.27%
Oct 31, 2025Leonid TimashevRBC Capital$215.00$194.5710.50%10.14%
Oct 31, 2025Trung HuynhUBS$223.00$194.0114.94%14.24%
Oct 31, 2025Wells Fargo$217.00$194.2211.73%11.17%
Oct 29, 2025Graig SuvannavejhMizuho Securities$196.00$166.9717.39%0.41%
Oct 28, 2025Cantor Fitzgerald$192.00$166.7715.13%-1.64%
Oct 14, 2025UBS$194.00$163.9418.34%-0.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025Cowen & Co.BuyBuyhold
Nov 20, 2025Cowen & Co.BuyBuyhold
Oct 31, 2025Goldman SachsBuyBuyhold
Oct 31, 2025RBC CapitalOutperformOutperformhold
Oct 31, 2025Wells FargoOverweightOverweighthold
Oct 30, 2025Cowen & Co.BuyBuyhold
Oct 14, 2025UBSBuyBuyhold
Oct 02, 2025Cowen & Co.BuyBuyhold
Oct 01, 2025Evercore ISIOutperformOutperformhold
Sep 08, 2025GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.01$-3.88$-3.91$-5.34$-5.57----
Avg Forecast$-2.60$-3.82$-3.72$-5.21$-5.36$-4.35$-2.65$0.86$4.09
High Forecast$-2.22$-3.26$-3.04$-5.10$-5.21$-3.10$-0.94$4.06$5.65
Low Forecast$-3.02$-4.43$-4.82$-5.34$-5.57$-5.38$-4.65$-0.81$3.23
Surprise %15.77%1.57%5.11%2.50%3.92%----

Revenue Forecast

$0 $800M $2B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$164.41M$188.46M$245.36M$305.21M$363.71M----
Avg Forecast$164.47M$179.85M$247.85M$303.42M$357.89M$506.74M$1.03B$1.94B$2.87B
High Forecast$184.87M$202.16M$304.60M$392.20M$364.25M$660.57M$1.04B$2.51B$3.71B
Low Forecast$145.97M$159.62M$213.35M$303.41M$351.53M$414.94M$1.02B$1.63B$2.40B
Surprise %-0.03%4.79%-1.00%0.59%1.62%----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-294.09M$-434.65M$-481.53M$-749.57M$-913.77M----
Avg Forecast$-250.25M$-400.47M$-434.01M$-749.57M$-757.05M$-595.36M$-478.57M$157.64M$574.37M
High Forecast$-200.20M$-320.37M$-347.20M$-599.65M$-732.14M$-435.02M$-131.70M$570.16M$792.86M
Low Forecast$-300.30M$-480.56M$-520.81M$-899.48M$-781.97M$-755.70M$-652.68M$-113.75M$453.50M
Surprise %17.52%8.54%10.95%-20.70%----

INSM Forecast FAQ

Is Insmed stock a buy?

Insmed stock has a consensus rating of Buy, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 31 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Insmed is a favorable investment for most analysts.

What is Insmed's price target?

Insmed's price target, set by 34 Wall Street analysts, averages $226.67 over the next 12 months. The price target range spans from $180 at the low end to $269 at the high end, suggesting a potential 16.12% change from the previous closing price of $195.2.

How does Insmed stock forecast compare to its benchmarks?

Insmed's stock forecast shows a 16.12% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Insmed over the past three months?

  • December 2025: 5.56% Strong Buy, 88.89% Buy, 5.56% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 15.79% Strong Buy, 78.95% Buy, 5.26% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 16.67% Strong Buy, 77.78% Buy, 5.56% Hold, 0% Sell, 0% Strong Sell.

What is Insmed’s EPS forecast?

Insmed's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.35, marking a -21.90% decrease from the reported $-5.57 in 2024. Estimates for the following years are $-2.65 in 2026, $0.86 in 2027, and $4.09 in 2028.

What is Insmed’s revenue forecast?

Insmed's average annual revenue forecast for its fiscal year ending in December 2025 is $506.74M, reflecting a 39.33% increase from the reported $363.71M in 2024. The forecast for 2026 is $1.03B, followed by $1.94B for 2027, and $2.87B for 2028.

What is Insmed’s net income forecast?

Insmed's net income forecast for the fiscal year ending in December 2025 stands at $-595M, representing a -34.85% decrease from the reported $-914M in 2024. Projections indicate $-479M in 2026, $157.64M in 2027, and $574.37M in 2028.